GenmabGMAB 
$26.20-0.87%24h
-0.87%24h
Global rank998
Market cap$17.11B
Change 7d-1.73%
YTD Performance-16.43%
SP500 benchmarkUnderperform
P/E3.97
P/S6.97
Revenue$2.45B
Earnings$648.34M
Dividend yield-
Main Sector
Healthcare
Market capitalization of Genmab (GMAB)
As of November 2024, Genmab has a market cap of $17.11B. This makes Genmab the world's 998th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Genmab from 2009 to 2024
-
Value:-
Market cap history of Genmab from 2009 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $18.43B | -11.37% |
| 2023 | $20.79B | -24.87% |
| 2022 | $27.68B | 7.13% |
| 2021 | $25.84B | -2.71% |
| 2020 | $26.55B | 82.09% |
| 2019 | $14.58B | 35.54% |
| 2018 | $10.76B | -0.61% |
| 2017 | $10.83B | -0.04% |
| 2016 | $10.83B | 23.73% |
| 2015 | $8.75B | 128.70% |
| 2014 | $3.83B | 49.72% |
| 2013 | $2.56B | 179.57% |
| 2012 | $914.34M | 114.07% |
| 2011 | $427.13M | -51.56% |
| 2010 | $881.68M | -10.60% |
| 2009 | $986.18M | - |
GMAB Market Cap Today is $17.11B -0.87% - 19 Nov 2024
View largest stocks by market cap 
